Kei Tomihara

9PUBLICATIONS
20CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 18, 2026
A case of Stevens-Johnson syndrome triggered by Mycoplasma infection.

Atsushi Uenoyama, Hideaki Hirai, Yuko Saito

|Dec 30, 2025
High CD36 Expression Predicts Aggressive Invasion and Recurrence in Oral Squamous Cell Carcinoma.

Kotaro Sakurai, Kei Tomihara, Manabu Yamazaki

|Sep 14, 2024
Targeting CD36-Mediated Lipid Metabolism by Selective Inhibitor-Augmented Antitumor Immune Responses in Oral Cancer.

Mayu Takaichi, Hidetake Tachinami, Danki Takatsuka

|May 25, 2024
Rapamycin Induces Phenotypic Alterations in Oral Cancer Cells That May Facilitate Antitumor T Cell Responses.

Amirmoezz Yonesi, Kei Tomihara, Danki Takatsuka

Pageof 2